查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1471956

血管接入设备市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按产品类型、应用、插入途径、最终用户和地理位置

Vascular Access Devices Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Application, Route of Insertion, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

血管通路器械市场预计将从2022年的56.2亿美元成长到2030年的102.9亿美元；预计2022年至2030年复合年增长率为7.9%。

使用多个解剖部位放置血管接取装置以连接上腔静脉或下腔静脉：颈内静脉、锁骨下静脉、颈外静脉和股静脉。市场规模的不断增长归因于慢性病盛行率的增加和化疗程序的增加。此外，公司为维持市场竞争力而采取的策略性措施也推动了市场的成长。支援人工智慧的机器人静脉存取设备的显着增加可能会在预测期内带来新的血管连接设备市场趋势。

越来越多的慢性病正在推动血管接入设备市场的成长

心血管、胃肠道疾病、类风湿性关节炎和神经系统疾病等慢性疾病会影响整体生活品质。据世界卫生组织 (WHO) 称，估计全球约 50% 的人口患有至少一种慢性病。根据2021 年发表的一项大规模跨国研究“功能性胃肠疾病的全球盛行率和负担，罗马基金会全球研究结果”，来自世界33 个国家的73,076 名成年人接受调查，约40% 患有功能性胃肠疾病紊乱（GFID）。与年龄相关的胃肠道问题在64岁及以上的老年人群中更为常见。根据 2022 年发表的题为「印度成年人胃肠道问题：印度纵向老化研究的证据」的研究，自我报告的胃肠道疾病盛行率约为 18%。研究也提到，世界各地肠胃问题的发生率各不相同，从伊朗的 14% 到一些西方国家的 54%。心血管疾病（CVD），尤其是与忙碌的生活方式相关的疾病，是全球死亡的重要原因。根据国际糖尿病联盟(IDF) 的数据，2021 年全球20 至79 岁之间有5.37 亿人患有糖尿病，预计到2045 年这一数字将增加到7.83 亿。死亡的原因。

老化会导致生理完整性持续丧失，导致功能下降和死亡风险增加。身体机能退化是老年患者感染大多数慢性疾病的关键危险因素，包括糖尿病、心血管疾病和神经系统疾病。据世界卫生组织称，到 2030 年，全球每 6 人中就有 1 人年龄在 60 岁以上。据同一来源称，60岁以上人口将从2020年的10亿增加到2030年的14亿。 。因此，由于上述因素，对血管通路装置的需求增加。

血管通路器械市场依产品类型分为短週边静脉导管、中线导管、PICC（週边插入中心导管）、中心导管、植入式端口和配件。中心导管再分为CICC（中央插入中心导管）、FICC（股动脉插入中心导管）等。 2022年，短週边静脉导管细分市场占据最大的血管通路器械市场份额，预计2022-2030年期间复合年增长率最高。

根据应用，市场分为药物管理、液体和营养管理、血液製品输注等。 2022年，给药领域占据最大的血管通路器械市场份额，预计2022-2030年期间复合年增长率最高。

根据插入途径，市场分为皮下注射和静脉注射。 2022 年，静脉注射细分市场在血管通路器械市场中占据较大份额，预计 2022-2030 年复合年增长率将更高。

根据最终用户，市场分为医院和诊所、门诊手术中心等。医院和诊所领域的血管通路装置市场规模可能在 2022 年至 2030 年期间激增。

根据地理位置，血管通路器械市场分为北美（美国、加拿大和墨西哥）、欧洲（英国、德国、法国、义大利、西班牙、俄罗斯和欧洲其他地区）、亚太地区（中国、日本、印度、韩国、澳大利亚和亚太地区其他地区）、中东和非洲（阿联酋、沙乌地阿拉伯、南非以及中东和非洲其他地区）以及南美洲和中美洲（巴西、阿根廷和其他地区）南美洲和中美洲）。北美是全球血管通路器械市场成长的最大贡献者。预计 2022 年至 2030 年，亚太地区血管通路器械市场复合年增长率最高。

世界卫生组织 (WHO)、疾病管制与预防中心 (CDC)、食品药物管理局 (FDA) 和国家医学图书馆 (NLM) 是在准备血管疾病报告时参考的一些关键的主要和次要来源。接入设备市场。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解
  • 市场吸引力分析

第 3 章：研究方法

第 4 章：血管接取设备市场格局

  • 概述
  • PEST分析
  • 生态系分析
    • 价值链供应商名单

第 5 章：血管接取设备市场 - 主要市场动态

  • 主要市场驱动因素
  • 主要市场限制
  • 主要市场机会
  • 未来的趋势
  • 驱动因素和限制因素的影响分析

第 6 章：血管接取装置市场 - 全球市场分析

  • 血管接入装置 - 全球市场概览
  • 血管接取装置 - 全球市场与 2030 年预测

第 7 章：血管接取设备市场 - 收入分析 - 按类型，2020-2030 年

  • 概述
  • 短週边静脉导管
  • 中线导管
  • 人保财险
  • 中央导管
  • 植入式连接埠
  • 配件

第 8 章：血管接取设备市场 - 收入分析 - 按应用划分，2020-2030 年

  • 概述
  • 药物管理
  • 输血
  • 液体和营养管理
  • 其他的

第 9 章：血管接取设备市场 - 收入分析 - 按最终用户，2020-2030 年

  • 概述
  • 医院和诊所
  • 门诊手术中心
  • 其他的

第 10 章：血管接取设备市场 - 收入分析，2020-2030 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥

註 - 将为以下提到的地区/国家提供类似的分析

  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 欧洲其他地区
  • 亚太
    • 澳洲
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 11 章：产业格局

  • 併购
  • 协议、合作、合资企业
  • 新产品发布
  • 扩张和其他策略发展

第 12 章：竞争格局

  • 关键参与者的热图分析
  • 公司定位与专注

第 13 章：血管接取设备市场 - 主要公司概况

  • B Braun Melsungen AG
  • NIPRO Medical Corporation
  • Smiths Medical
  • Becton, Dickinson, and Company
  • Terumo Corporation
  • Teleflex Incorporated
  • Edwards Lifesciences Corporation
  • AngioDynamics
  • Ameco Medical
  • Vygon Ltd

第 14 章：附录

简介目录
Product Code: TIPHE100000983

The vascular access devices market is expected to grow from US$ 5.62 billion in 2022 to US$ 10.29 billion by 2030; it is anticipated to record a CAGR of 7.9% from 2022 to 2030.

Vascular access devices are placed using a number of anatomic sites to access the superior or inferior vena cava: the internal jugular vein, subclavian vein, external jugular vein, and femoral vein. The growing market size is attributed to the increasing prevalence of chronic diseases and increasing chemotherapy procedures. In addition, strategic initiatives by companies to stay competitive in the market are fueling the market growth. Significant increase in AI-enabled robotic venous access devices will likely bring new vascular access devices market trends during the forecast period.

Growing Number of Chronic Diseases are Fueling the Vascular Access Devices Market Growth

Chronic disorders such as cardiovascular, gastrointestinal disorders, rheumatoid arthritis, and neurological disorders affect the overall quality of life. According to the World Health Organization (WHO), about 50% of the global population is estimated to suffer from at least one chronic disease. According to the "Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study," a large-scale multinational study published in 2021, ~40% of 73,076 adults surveyed from 33 countries in the world were suffering from a functional gastrointestinal disorder (GFID). Age-related gastrointestinal problems are more common in the elderly population, aged 64 and above. Per the study titled "Gastrointestinal problem among Indian adults: Evidence from Longitudinal Aging Study in India", published in 2022, self-reported gastrointestinal disorders prevalence was reported at ~18%. The study also mentions that varying rates of gastrointestinal problems have been observed across the world, ranging from 14% in Iran to 54% in some western countries. Cardiovascular diseases (CVDs), especially the cases associated with hectic lifestyles, are a significant cause of mortality globally. According to the International Diabetes Federation (IDF), 537 million people worldwide, aged 20-79, had diabetes in 2021, and the number is estimated to increase to 783 million by 2045. Additionally, diabetes was the cause of 6.7 million deaths worldwide in 2021.

Aging can cause a consistent loss of physiological integrity, resulting in a reduction in functionality and an increased risk of mortality. The degradation of body function is a key risk factor for contracting the majority of chronic diseases, including diabetes, CVD, and neurological diseases, among elderly patients. According to the WHO, by 2030, 1 in 6 people worldwide will be aged above 60 years. As per the same source, the population aged above 60 years will increase from 1 billion in 2020 to 1.4 billion in 2030. With the increasing prevalence of chronic disorders and growing geriatric population, the number of patients who require drugs and nutrition through their venous system is increasing. Hence, due to above mentioned factors there is increase in demand for vascular access devices.

The vascular access devices market, by product type, is segmented into short peripheral intravenous catheters, midline catheters, PICC (peripherally inserted central catheters), central catheter, implantable ports, and accessories. Central catheter is further divided into CICC (centrally inserted central catheter), FICC (femorally inserted central catheter), and others. In 2022, the short peripheral intravenous catheter segment held the largest vascular access devices market share and is expected to record the highest CAGR during 2022-2030.

Based on application, the market is segmented into drug administration, administration of fluid & nutrition, transfusion of blood products, and others. In 2022, the drug administration segment held the largest vascular access devices market share and is projected to record the highest CAGR during 2022-2030.

Based on route of insertion, the market is bifurcated into subcutaneous and intravenous. The intravenous segment held a larger share of the vascular access devices market in 2022 and is anticipated to record a higher CAGR during 2022-2030.

Based on end user, the market is divided into hospitals and clinics, ambulatory surgical center, and others. The vascular access devices market size for the hospitals and clinics segment is likely to surge during 2022-2030.

Based on geography, the vascular access devices market is segmented into North America (theUS, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America). North America is the largest contributor to the growth of the global vascular access devices market. Asia Pacific is predicted to show the highest CAGR in the vascular access devices market during 2022-2030.

World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and National Library of Medicine (NLM) are a few key primary and secondary sources referred to while preparing the report on the vascular access devices market.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Vascular Access Devices Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Vascular Access Devices Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Vascular Access Devices Market - Global Market Analysis

  • 6.1 Vascular Access Devices - Global Market Overview
  • 6.2 Vascular Access Devices - Global Market and Forecast to 2030

7. Vascular Access Devices Market - Revenue Analysis (USD Million) - By Type, 2020-2030

  • 7.1 Overview
  • 7.2 Short Peripheral Intravenous Catheters
  • 7.3 Midline Catheters
  • 7.4 PICC
  • 7.5 Central Catheters
    • 7.5.1 Centrally Inserted central Catheters
    • 7.5.2 Femoral Inserted Central Catheters
  • 7.6 Implantable Ports
  • 7.7 Accessories

8. Vascular Access Devices Market - Revenue Analysis (USD Million) - By Application, 2020-2030

  • 8.1 Overview
  • 8.2 Drug Administration
  • 8.3 Blood Transfusion
  • 8.4 Fluid and Nutrition Administration
  • 8.5 Others

9. Vascular Access Devices Market - Revenue Analysis (USD Million) - By End User, 2020-2030

  • 9.1 Overview
  • 9.2 Hospitals and Clinics
  • 9.3 Ambulatory Surgical Centers
  • 9.4 Others

10. Vascular Access Devices Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

  • 10.1 North America
    • 10.1.1 North America Vascular Access Devices Market Overview
    • 10.1.2 North America Vascular Access Devices Market Revenue and Forecasts to 2030
    • 10.1.3 North America Vascular Access Devices Market Revenue and Forecasts and Analysis - By Type
    • 10.1.4 North America Vascular Access Devices Market Revenue and Forecasts and Analysis - By Application
    • 10.1.5 North America Vascular Access Devices Market Revenue and Forecasts and Analysis - By End User
    • 10.1.6 North America Vascular Access Devices Market Revenue and Forecasts and Analysis - By Countries
      • 10.1.6.1 United States Vascular Access Devices Market
        • 10.1.6.1.1 United States Vascular Access Devices Market, by Type
        • 10.1.6.1.2 United States Vascular Access Devices Market, by Application
        • 10.1.6.1.3 United States Vascular Access Devices Market, by End User
      • 10.1.6.2 Canada Vascular Access Devices Market
        • 10.1.6.2.1 Canada Vascular Access Devices Market, by Type
        • 10.1.6.2.2 Canada Vascular Access Devices Market, by Application
        • 10.1.6.2.3 Canada Vascular Access Devices Market, by End User
      • 10.1.6.3 Mexico Vascular Access Devices Market
        • 10.1.6.3.1 Mexico Vascular Access Devices Market, by Type
        • 10.1.6.3.2 Mexico Vascular Access Devices Market, by Application
        • 10.1.6.3.3 Mexico Vascular Access Devices Market, by End User

Note - Similar analysis would be provided for below mentioned regions/countries

  • 10.2 Europe
    • 10.2.1 Germany
    • 10.2.2 France
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Rest of Europe
  • 10.3 Asia-Pacific
    • 10.3.1 Australia
    • 10.3.2 China
    • 10.3.3 India
    • 10.3.4 Japan
    • 10.3.5 South Korea
    • 10.3.6 Rest of Asia-Pacific
  • 10.4 Middle East and Africa
    • 10.4.1 South Africa
    • 10.4.2 Saudi Arabia
    • 10.4.3 U.A.E
    • 10.4.4 Rest of Middle East and Africa
  • 10.5 South and Central America
    • 10.5.1 Brazil
    • 10.5.2 Argentina
    • 10.5.3 Rest of South and Central America

11. Industry Landscape

  • 11.1 Mergers and Acquisitions
  • 11.2 Agreements, Collaborations, Joint Ventures
  • 11.3 New Product Launches
  • 11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

  • 12.1 Heat Map Analysis by Key Players
  • 12.2 Company Positioning and Concentration

13. Vascular Access Devices Market - Key Company Profiles

  • 13.1 B Braun Melsungen AG
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments

Note - Similar information would be provided for below list of companies

  • 13.2 NIPRO Medical Corporation
  • 13.3 Smiths Medical
  • 13.4 Becton, Dickinson, and Company
  • 13.5 Terumo Corporation
  • 13.6 Teleflex Incorporated
  • 13.7 Edwards Lifesciences Corporation
  • 13.8 AngioDynamics
  • 13.9 Ameco Medical
  • 13.10 Vygon Ltd

14. Appendix

  • 14.1 Glossary
  • 14.2 About The Insight Partners
  • 14.3 Market Intelligence Cloud